CYTK – Cytokinetics, Incorporated

CYTK — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

13.01

Margin Of Safety %

Put/Call OI Ratio

0.32

EPS Next Q Diff

-0.17

EPS Last/This Y

0.01

EPS This/Next Y

1.6

Price

65.5

Target Price

93.22

Analyst Recom

1.33

Performance Q

6.89

Upside

-449.0%

Beta

0.46

Ticker: CYTK

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-09	CYTK	62.41	0.24	0.03	101442
2026-03-10	CYTK	64.24	0.24	0.41	102724
2026-03-11	CYTK	63.6	0.24	0.05	106273
2026-03-12	CYTK	60.02	0.24	2.84	110580
2026-03-13	CYTK	60	0.24	2.85	110580
2026-03-17	CYTK	62.16	0.28	0.89	122620
2026-03-18	CYTK	62.23	0.29	0.36	125670
2026-03-19	CYTK	62.93	0.30	2.77	126959
2026-03-20	CYTK	61.69	0.32	0.20	129882
2026-03-23	CYTK	60.94	0.30	0.70	114553
2026-03-24	CYTK	60.04	0.30	0.27	116909
2026-03-25	CYTK	62.37	0.30	0.07	118466
2026-03-26	CYTK	63.47	0.30	1.11	119785
2026-03-27	CYTK	62.52	0.30	0.75	121370
2026-03-30	CYTK	62.96	0.31	0.54	123755
2026-03-31	CYTK	65.88	0.32	0.14	124113
2026-04-01	CYTK	66.6	0.31	0.32	125016
2026-04-02	CYTK	66.72	0.32	0.19	127345
2026-04-06	CYTK	64.93	0.32	4.73	129700
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-09	CYTK	62.40	-18.7	-34.2	-6.44
2026-03-10	CYTK	64.30	-18.7	-32.7	-6.44
2026-03-11	CYTK	63.65	-18.7	-6.6	-6.44
2026-03-12	CYTK	60.01	-18.7	25.0	-6.44
2026-03-13	CYTK	60.08	-18.7	-13.2	-6.44
2026-03-17	CYTK	62.14	-18.7	-26.7	-6.44
2026-03-18	CYTK	62.19	-18.7	-13.3	-6.44
2026-03-19	CYTK	62.93	-18.7	-76.8	-6.44
2026-03-20	CYTK	61.70	-20.2	-53.9	-6.51
2026-03-23	CYTK	60.96	-20.2	-59.8	-6.51
2026-03-24	CYTK	60.04	-20.9	-57.7	-6.54
2026-03-25	CYTK	62.35	-20.9	-95.5	-6.54
2026-03-26	CYTK	63.53	-20.9	-81.4	-6.54
2026-03-27	CYTK	62.50	-20.9	-57.5	-6.54
2026-03-30	CYTK	62.98	-20.2	-73.2	-6.54
2026-03-31	CYTK	65.90	-20.2	-101.3	-6.54
2026-04-01	CYTK	66.58	-20.2	-75.6	-6.54
2026-04-02	CYTK	66.72	-20.2	-69.6	-6.54
2026-04-06	CYTK	64.96	-20.2	-49.4	-6.54
2026-04-07	CYTK	65.50	-20.2	-74.2	-6.54
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-09	CYTK	-8.02	-2.84	12.28
2026-03-10	CYTK	-8.02	-2.84	12.28
2026-03-11	CYTK	-8.37	-2.84	12.77
2026-03-12	CYTK	-8.37	-2.84	12.77
2026-03-13	CYTK	-8.37	-2.84	12.77
2026-03-17	CYTK	-8.27	-2.84	12.77
2026-03-18	CYTK	-8.33	-2.84	12.77
2026-03-19	CYTK	-10.16	-2.84	12.77
2026-03-20	CYTK	-10.16	-2.84	12.77
2026-03-23	CYTK	-10.16	-2.83	12.77
2026-03-24	CYTK	-10.10	-2.83	12.77
2026-03-25	CYTK	-10.10	-2.83	13.01
2026-03-26	CYTK	-10.10	-2.83	13.01
2026-03-27	CYTK	-10.10	-2.83	13.01
2026-03-30	CYTK	-10.10	-2.85	13.01
2026-03-31	CYTK	-10.20	-2.85	13.01
2026-04-01	CYTK	-10.08	-2.85	13.01
2026-04-02	CYTK	-10.08	-2.85	13.01
2026-04-06	CYTK	-10.08	-2.86	13.01
2026-04-07	CYTK	-9.89	-2.86	13.01
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-1.5

Avg. EPS Est. Current Quarter

-1.63

Avg. EPS Est. Next Quarter

-1.67

Insider Transactions

-9.89

Institutional Transactions

-2.86

Beta

0.46

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

40.6

Max Drawdown 5-Year %

-72.4

Target Price

93.22

P/E

Forward P/E

PEG

P/S

91.6

P/B

P/Free Cash Flow

EPS

-6.53

Average EPS Est. Cur. Y

-6.54

EPS Next Y. (Est.)

-4.93

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-891.6

Relative Volume

0.68

Return on Equity vs Sector %

91.5

Return on Equity vs Industry %

108.1

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.03

EBIT Estimation

-74.2

◆ CYTK Healthcare

$65.48

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

0/20

Pullback

10/25

Volume

6/15

Valuation

8/20

TP/AR

4/10

Options

0/10

RSI

56.1

Range 1M

67.4%

Sup Dist

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

5/25

Growth

13/30

Estimates

3/20

Inst/Vol

2/15

Options

0/10

EPS Yr

EPS NY

27.4%

52W%

86.5%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +42.4% upside

Quality

7/30

Valuation

10/30

Growth

9/25

Stability

8/10

LT Trend

1/5

Upside

+42.4%

Quality

Cytokinetics, Incorporated

Sector: Healthcare

Industry: Biotechnology

Employees: 673

Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of HCM; and omecamtiv mecarbil, a potential treatment across the continuum of care in heart failure with severely reduced ejection fraction. In addition, the company is involved in developing and Ulacamten, a novel, selective, oral, and small molecule cardiac myosin inhibitor designed to reduce the hypercontractility associated with heart failure with preserved ejection fraction in Phase 1 clinical trials; and CK-089, a fast skeletal muscle troponin activator in Phase 1 clinical trials. Cytokinetics, Incorporated was incorporated in 1997 and is headquartered in South San Francisco, California.

CYTK

Latest News

—

Caricamento notizie per CYTK…

stock quote shares CYTK – Cytokinetics, Incorporated Stock Price stock today

news today CYTK – Cytokinetics, Incorporated stock forecast ,stock prediction 2023 2024 2025

marketwatch CYTK – Cytokinetics, Incorporated yahoo finance google finance

stock history CYTK – Cytokinetics, Incorporated invest stock market

stock prices CYTK premarket after hours

ticker CYTK fair value insiders trading

CYTK – Cytokinetics, Incorporated

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: CYTK

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y